> Influqim-R

Vaccine against Equine Influenza (Horse Flu) and Equine Rhinopneumonitis.

High protection in respiratory pathologies. The incorporation of Equine Herpes Virus 1 and 4 to the Influqim vaccine provides broad-spectrum protection against the most prevalent respiratory diseases in horses.

Dose
2 ml.
Intramuscular Route
Administration

Foals 3-8 months of age: 2 doses, 4-8 weeks apart. Equines in transit through the country: 1 dose every 3 months (March, June, September and December). Equines used in rural tasks: 1 dose every 6 months or according to professional criteria.

Content

Bottle containing 10 ml / 5 doses - 20 ml / 5 doses

Composition

Inactivated Equine Influenza Viruses Updated Viral Strains; Equine Herpes Virus 1 and Equine Herpes Virus 4; Preservatives: Metorgan and Gentamicin. Adjuvant: Aluminum Gel.

Related Products

Respiratory

Influqim RT

Vaccine against Equine Influenza (Horse Flu), Equine Rhinopneumonitis and Tetanus. With nonspecific immunostimulant.

,
Nonspecific immunostimulant, Vitamin restoratives

Vigormeq

Mineralizing restorative tonic with amino acids and vitamins

Respiratory

Influqim

Vaccine against Equine Influenza (Equine Flu)

Reproductive

Rinoqim

Vaccine against equine rhinopneumonitis.

Neonatal

Rotamix Equin

Vaccine used as an adjuvant against neonatal diarrhea in foals caused by Rotavirus and Escherichia coli